• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number T175
Device Problem Protective Measures Problem (3015)
Patient Problem Fall (1848)
Event Date 07/20/2016
Event Type  Injury  
Manufacturer Narrative
This investigation will be updated should further information be provided.
 
Event Description
Boston scientific received information that this patient presented to the hospital due to pre syncope with a fall.The patient has a history of polymorphic ventricular tachycardia.When the device was interrogated nothing was stored and the device had triggered elective replacement indicator (eri).A device change out was planned.The cause of the pre syncope and fall was not confirmed.
 
Manufacturer Narrative
At this time, the product has not been returned.If the product is returned, analysis will be performed and this report would be updated at that time.
 
Event Description
Additional information noted no information regarding the fall was obtained.It was noted that this device was explanted due to the device being at eri, the device will be returned.No allegations when it comes to the device was noted.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.A visual inspection of the device header and case noted no anomalies.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITALITY 2
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 
6515824786
MDR Report Key6020538
MDR Text Key57090191
Report Number2124215-2016-11783
Device Sequence Number1
Product Code KRG
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 10/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/11/2009
Device Model NumberT175
Other Device ID NumberVITALITY 2 VR
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/30/2016
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received10/14/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/19/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0158; T175
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age76 YR
-
-